# OnCo record iaso-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/iaso-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "iaso-bio" ;
  schema:name "IASO Biotherapeutics"@en ;
  schema:alternateName "驯鹿生物"@en, "IASO Bio"@en ;
  schema:description "IASO Bio developed eque-cel, the fully human BCMA CAR-T for myeloma approved in China in 2023 and partnered with Innovent."@en ;
  schema:url <https://onco.cc/companies/iaso-bio/>, <https://www.iasobio.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.iasobio.com/> ;
  onco:tag "china" ;
  schema:addressCountry "CN" ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:drugs <https://onco.cc/drugs/equecabtagene-autoleucel/> ;
  onco:companies <https://onco.cc/companies/innovent/> ;
  onco:institutions <https://onco.cc/institutions/tongji-hospital-wuhan/> .